Polymeric micelles for the targeting of hydrophobic drugs

Polymeric Drug Delivery Systems

Volumn , Issue , 2005, Pages 533-575

  Yokoyama, Masayuki ^a  

^a KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32244438595     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (84)

1. Tuzar Z, Kratochvil P. Block and graft copolymer micelles in solution. Adv Colloid Interf Sci 1976; 6:201-232.
2. Yokoyama M, Inoue S, Kataoka K, Yui N, Okano T, Sakurai Y. Molecular design for missile drug: Synthesis of adriamycin conjugated with IgG using poly(ethylene glycoel)-poly(aspartic acid) block copolymer as intermediate carrier. Die Makromolekulare Chemie 1989; 190:2041-2054.
3. Kabanov AV, Chekhonin VP, Alakhov VY, Batrakova EV, Lebedev AS, Melik-Nubarov NS, Arzhakov SA, Levashov AV, Morozov GV, Severin ES, Kabanov VA. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: Micelles as microcontainers for drug targeting. FEBS Lett 1989; 258:343-345.
4. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K, Sakurai Y, Okano T. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Controlled Release 1998; 50:79-92.
5. Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T, Kataoka K. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Controlled Release 1998; 55:219-229.
6. Li Y, Kwon GS. Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part 1: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res 2000; 17:607-611.
7. Lavasanifar A, Samuel I, Kwon GS. The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles compoased of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide). J Contr Rel 2002; 79:165-172.
8. Allen C, Han J, Yu Y, Maysinger D, Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J Contr Rel 2000; 51:275-286.
9. Trubetskoy VS, Torchilin VP. Polyethyleneglycol based micelles as carriers of the therapeutic and diagnostic agents. STP Pharma Sci 1996; 6:79-86.
10. Zhang X, Burt H-M, Von Hoff D, Dexter D, Mangold G, Degen D, Oktaba AM, Hunter W-L. An investigation of the antitumor activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother Pharmacol 1997; 40:81-86.
11. Rolland A, O’Mullane J, Goddard P, Brookman L, Petrak K. New macromolecular carriers for drugs. I. Preparation and characterization of poly(oxyethylene-b-isoprene-b-oxyethylene) block copolymer aggregates. J Appl Polym Sci 1992; 44: 1195-1203.
12. Inoue T, Chen G, Nakamae K, Hoffman AS. An AB block co polymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. J Contr Rel 1998; 41: 21-229.
13. Rapoport NY, Herron JN, Pitt WG, Pitina L. Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: Effect of micelle structure and ultrasound on the intracellular drug uptake. J Contr Rel 1999; 58:153-162.
14. Benahmed A, Ranger M, Leroux J-C. Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D, L-lactide). Pharm Res 2001; 18:323-328.
15. Nishiyama N, Yokoyama M, Aoyagi T, Okano T, Sakurai Y, Kataoka K. Preparation and characterization of selfassembled polymer-metal complex micelle from cis-dichlorodiammineplatinum (II) and poly(ethylene glycol)-poly(a, p-aspartic acid) block copolymer in an aqueous medium. Langmuir 1999; 15:377-383.
16. Kataoka K, Togawa H, Harada A, Yasugi K, Matsumoto T, Katayose S. Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules 1996; 29:8556-8557.
17. Harada A, Kataoka K. Novel polyion complex micelles entrapping enzyme molecules in the core: Preparation of narrowlydistributed micelles from lysozyme and poly(ethylene glycol)-poly(aspartic acid) block copolymer in aqueous medium. Macromolecules 1998; 31:288-294.
18. Calderara F, Hruska Z, Hurtrez G, Lerch J-P, Nugay T, Riess G. Investigation of olystyrene-poly(ethylene oxide)block copolymer micelle formation in organic and aqueous solutions by nonradiative energy transfer experiments. Macromolecules 1994; 27:1210-1215.
19. Wang Y, Kausch C-M, Chun M, Quirk R-P, Mattice WL. Exchange of chains between micelles of labeled polysty rene-block-poly(oxyethylene) as monitored by nonradiative singlet energy transfer. Macromolecules 1995; 28:904-911.
20. Wilhelm M, Zhao C-L, Wang Y, Xu R, Winnik R-A. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: A fluorescence probe study. Macromolecules 1991; 24:1033-1040.
21. Desjardins A, Eisenberg A. Colloidal properties of block ionomers. 1.4 Characterization of reverse micelles of styrene-bmetal methacrylate diblocks by size-exclusion chromatography. Macromolecules 1991; 24:5779-5790.
22. Hoes CJT, Potman W, van Heeswijk WAR, Mud J, de Grooth B-G, Grave I, Feijen J. Optimization of macromolecular prodrugs of the antitumor antibiotic adriamycin. J Contr Rel 1985; 2:205-213.
23. Duncan R, Kopeckova-Rejmanova P, Strohalm J, Hume I, Cable HC, Pohl J, Lloyd JB, Kopecek J. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer 1987; 55:165-174.
24. Endo N, Umemoto N, Kato Y, Takeda Y, Hara T. A novel covalent modification of antibodies at their amino groups with retention of antigen-binding activity. J Immunol Meth 1987; 104:253-258.
25. Zunino F, Pratesi G, Micheloni A. Poly(carboxylic acid) polymers as carriers for anthracyclines. J Contr Rel 1989; 10: 65-73.
26. Hirano T, Ohashi S, Morimoto S, Tsukada K, Kobayashi T, Tsukagoshi S. Synthesis of antitumor-active conjugates of adriamycin or daunomycin with the copolymer of divinyl ether maleic anhydride. Makromol Chem 1986; 187:2815-2824.
27. Tsukada Y, Kato Y, Umemoto N, Takeda Y, Hara T, Hirai H. An anti-oc-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier. J Natl Cancer Inst 73; 1984:721-729.
28. Yokoyama M, Kwon GS, Okano T, Sakurai Y, Seto T, Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconj Chem 1992; 3:295-301.
29. Yokoyama M, Okano T. Targetable drug carriers: Present status and a future perspective. Adv Drug Delivery Rev 1996; 21:77-80.
30. Sugiyama Y. Importance of pharmacokinetic considerations in the development of drug delivery systems. Adv Drug Delivery Rev 1996; 19:333-334.
31. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of turn or tropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46:6387-6392.
32. Maeda H, Seymour L-W, Miyamoto Y. Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconj Chem 1992; 3:351-361.
33. Litzinger DC, Buiting A-M-J, van Rooijen N, Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta 1994; 1190:99-107.
34. Takakura Y, Hashida M. Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic consideration on biodistribution. Pharm Res 1996; 13:820-831.
35. Ilium L, Davis SS, Miller R-H, Mak E, West P. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer-Poloxamine 908. Life Sci 1987; 40:367-374.
36. Bader H, Ringsdorf H, Schmidt B. Water soluble polymers in medicine. Angew Chem 1984; 123/124:457-485.
37. Pratten MK, Lloyd JB, Horpel G, Ringsdorf H. Micelle-forming block copolymers: Pinocytosis by macrophages and interaction with model membranes. Makromol Chem 1985; 186:725-733.
38. Kabanov AV, et al. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: Micelles as microcontainers for drug targeting. FEBS Lett 1989; 258:343-345.
39. Kabanov A-V, Alakhov VY. Micelles of amphiphilic block copolymers as vehicles for drug delivery. Alexandridis P, Lindman B, eds. Amphiphilic Block Copolymers: Self Assembly and Applications. Netherlands: Elsevier, 1997:1-31.
40. Kabanov AV. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activity. Br J Cancer 1996; 74:1545-1552.
41. Yokoyama M, Inoue S, Kataoka K, Yui N, Sakurai Y. Preparation of adriamycin-conjugated poly(ethylene glycol)-poly-(aspartic acid) block copolymer. A new type of polymeric anticancer agent. Makromolekul Chemi Rapid Commun 1987; 8:431-435.
42. Yokoyama M, Inoue S, Kataoka K, Yui N, Sakurai Y. Molecular design for missile drug: Synthesis of adriamycin conjugated with IgG using poly(ethylene glycol)-poly(aspartic acid) block copolymer as intermediate carrier. Makromol Chem 1989; 190:2041-2054.
43. Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Inoue S. Characterization and anti-cancer activity of micelle-forming polymeric anti-cancer drug, adriamycinconjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 1990; 50:1693-1700.
44. Yokoyama M, Yamada N, Okano X, Sakurai Y, Kataoka K, Inoue S. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric drug and its extremely long circulation in blood. Cancer Res 1991; 51:3229-3236.
45. Kwon GS, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxideaspartate) block copolymer-adriamycin conjugates. J Contr Rel 1994; 29:17-23.
46. Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kataoka K. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Target 1999; 7:171-186.
47. Newman KD, Samuel J, Kwon GS. Ovalbumin peptide encapsulated in Poly(d, l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. J Contr Rel 1998; 54:49-59.
48. Yu BG, Okano T, Kataoka K, Kwon GS. Polymeric micelles for drug delivery: Solubilization and haemolytic activity of amphotericin B. J Contr Rel 1998; 53:131-136.
49. Yu BG, Okano T, Kataoka K, Sardari S, Kwon GS. In vitro dissociation of antifungal efficacy and toxicity for amphotericin Bloaded poly(ethylene oxide)-block-poly((3-benzyl-L-aspartate) micelles. J Contr Rel 1998; 56:285-291.
50. Rolland A, O’Mullane J, Goddard L, Brookman L, Petrak K. New macromolecular carriers for drugs. 1. Preparation and characterization of poly(oxyethylene-b-isoprene-b-oxyethylene)block copolymer aggregates. J Appl Polym Sci 1992; 44:1195-1203.
51. Shin IL, Kim SY, Lee YM, Cho CS, Sung YK. Methoxy polyethylene glycol)/e-caprolactone amphiphilic block copolymeric micelle containing indomethacin 1. Preparation and characterization. J Contr Rel 1998; 51:1-11.
52. Allen C, Han J, Yu Y, Maysinger D, Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J Contr Rel 2000; 63:275-286.
53. Inoue T, Chen G, Nakamae K, Hoffman AS. An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. J Contr Rel 1998; 51:221-229.
54. Hagan SA, Coombes AGA, Garnett MC, Dunn SE, Davies MC, Ilium L, Davies SS. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. Characterization of water dispersible micelle-forming systems. Langmuir 1996; 12:2153-2161.
55. Trubetskoy VS, Torchilin VP. Polyethyleneglycol based micelles as carriers of therapeutic and diagnostic agents. STP Pharma Sci 1996; 6:79-86.
56. Piskin E, Kaitian X, Denkbas EB, Kucukyavuz Z. Novel PDLLA/PEG copolymer micelles as drug carriers. J Biomater Sci Polymer Edn 1995; 7:359-373.
57. Gref R, Minamitake Y, Peracchia MT, Torchilin V, Trubetskoy V, Langer R. Biodegradable long-circulating nanospheres. Science 1994; 28:1600.
58. Ha JC, Kim SY, Lee YM. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)(plueronic/poly(e-caprolactone) (PCL) amphiphilic block copolymeric nanospheres I. Preparation and characterization. J Contr Rel 1995; 62:381-392.
59. Verrecchia T, Spenlehauer G, Bazile DV, Murry-Brelier A, Archimbaud Y, Veillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J Contr Rel 1995; 36:49-61.
60. Prochazka K, Kiserow D, Ramireddy C, Tuzar Z, Munk P, Webber SE. Time-resolved fluorescence studies on the chain dynamics of naphthalene-labeled polystyrene-block-poly-(methacrylic acid) micelles in aqueous media. Macromolecules 1992; 25:454-460.
61. Ganachaud E, Monteiro MJ, Gilbert RG, Dourges MA, Thang SH, Rizzaedo E. Molecular weight characterization of poly(Nisopropylacrylamide) prepared by living free-radical polymerization. Macromolecules 2000; 33:6738-6745.
62. Kwon GS, Yokohama M, Okano T, Sakurai Y, Kataoka K. Biodistribution of micelle-forming polymer-drug conjugates. Pharm Res 1993; 10:970-974.
63. Yokoyama M, Kwon GS, Okano T, Sakurai Y, Ekimoto H, Okamoto K, Mashiba H, Seto T, Kataoka K. Compositiondependent in vivo antitumor activity of adriamycin-conjugated polymeric micelle against murine colon adenocarcinoma 26. Drug Delivery 1993; 1:11-19.
64. Yokoyama M, Kwon GS, Okano T, Sakurai Y, Kataoka K. Influencing factors on in vitro micelle stability of adriamycin-block copolymer conjugates. J Contr Rel 1994; 28:59-65.
65. Kabanov AV, Alakhov VY. Micelles of amphiphilic block copolymers as vehicles for drug delivery. In: Alexandridis P, Lindman B, eds. Amphiphilic Block Copolymers: Self Assembly and Applications. Netherlands: Elsevier, 1997: 1-31.
66. Scholz C, Iijima M, Nagasaki Y, Kataoka K. A novel reactive polymeric micelle with aldehyde groups on its surface. Macromolecules 1995; 28:7295-7297.
67. Chung J-E, Yokoyama M, Aoyagi T, Sakurai Y, Okano T. Effect of molecular architecture of hydrophobically modified poly(N-isopropylacrylamide) on the formation of thermoresponsive core-shell micellar drug carriers. J Contr Rel 1998; 53:119-130.
68. Kohori F, Sakai K, Aoyagi T, Yokoyama M, Sakurai Y, Okano T. Preparation and characterization of thermally responsive block copolymer micelles comprising poly(Nisopropylacrylamide-b-DL-lactide). J Contr Rel 1998; 55: 87-98.
69. Chung JE, Yokoyama M, Yamato M, Aoyagi T, Sakurai Y, Okano T. Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). J Contr Rel 1999; 62:115-127.
70. Kohori F, Sakai K, Aoyagi T, Yokoyama M, Yamato M, Sakurai Y, Okano T. Control of adriamycin cytotoxic activity using thermally responsive polymeric micelles composed of poly(N-isopropylacrylamide-co-N, N-dimethylacrylamide)-bpoly(DL-lactide). Colloid Surf B 1999; 16:195-205.
71. Chung JE, Yokoyama M, Okano T. Inner core segment design for drug delivery control of thermo-responsive polymeric micelles. J Contr Rel 2000; 65:93-103.
72. Kohori F, Yokoyama M, Sakai K, Okano T. Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. J Contr Rel 2002; 78:155-163.
73. Kwon GS, Naito M, Kataoka K, Yokoyama M, Sakurai Y, Okano T. Block copolymer micelles as vehicles for hydrophobic drugs. Colloid Surf B 1994; 2:429-434.
74. Yokoyama M, Okano T, Sakurai Y, Kataoka K. Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly-(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Contr Rel 1994; 32:269-277.
75. Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Physical entrapment of adriamycin in AB block copolymer micelles. Pharm Res 1995; 12:192-195.
76. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K, Sakurai Y, Okano T. Characterization of physically entrapment and chemically conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Contr Rel 1998; 50:79-92.
77. Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T, Kataoka K. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Contr Rel 1998; 55:219-229.
78. Matsumura Y, Yokoyama M, Kataoka K, Okano T, Sakurai Y, Kawaguchi T, Kakizoe T. Reduction of the adverse effects of an antitumor agent, KRN 5500 by incorporation of the drug into polymeric micelles. Jap J Cancer Res 1999; 90:122-128.
79. Mizumura Y, Matsumura Y, Yokoyama M, Okano T, Kawaguchi T, Moriyasu F, Kakizoe T. Incorporation of the anticancer agent KRN 5500 into polymeric micelles diminishes the pulmonary toxicity. Jap J Cancer Res 2002; 93:1237-1243.
80. Nishiyama N, Yokoyama M, Aoyagi T, Okano T, Sakurai Y, Kataoka K. Preparation and characterization of selfassembled polymer-metal complex micelle from cis-dichlorodiammineplatinum (II) and poly(ethylene glycol)-poly(a, p-aspartic acid) block copolymer in an aqueous medium. Langmuir 1999; 15:377-383.
81. Lavasanifar A, Samuel J, Satari S, Kwon GS. Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharm Res 2002; 19:418-422.
82. Lavasanifar A, Samuel J, Kwon GS. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method; effect on the solubilization and hemolytic activity of amphotericin B. J Contr Rel 2001; 77:155-160.
83. Adams ML, Kwon GS. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length. J Contr Rel 2003; 87:23-32.
84. Li Y, Kwon GS. Methotrexate ester of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part 1: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res 2000; 157:607-611.